These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The measurement of complement fixation by autoantibodies directed against thyroid membrane antigens. Parkes AB; Williams S; Howells RD; Harris R; Lazarus JH; Waters JS; Hall R J Clin Lab Immunol; 1991 May; 35(1):1-7. PubMed ID: 1668285 [TBL] [Abstract][Full Text] [Related]
29. [Animal models for autoimmune thyroid disease]. Nishikawa M; Iwasaka T Nihon Rinsho; 1999 Aug; 57(8):1723-8. PubMed ID: 10483240 [TBL] [Abstract][Full Text] [Related]
30. Effect of solubilization of porcine thyrotropin (TSH) receptor on TSH binding and on radio-receptor assay for anti-TSH receptor antibodies. Watanabe Y; Tada H; Hidaka Y; Takano T; Amino N Biochem Biophys Res Commun; 1998 Jul; 248(1):110-4. PubMed ID: 9675095 [TBL] [Abstract][Full Text] [Related]
31. The thyrotropin receptor in thyroid diseases. Paschke R; Ludgate M N Engl J Med; 1997 Dec; 337(23):1675-81. PubMed ID: 9385128 [No Abstract] [Full Text] [Related]
32. Immune response potential and its genetic regulation in autoimmune diseases. Alterations in systemic lupus erythematosus and thyroid autoimmune diseases. Bentwich Z; Shalev Y; Segal R; Katz D; Mozes E Ann N Y Acad Sci; 1986; 475():227-30. PubMed ID: 2947529 [No Abstract] [Full Text] [Related]
34. Polymorphisms in the protein tyrosine phosphatase (PTPN22) gene is not associated with autoimmune thyroid in a large affected Tunisian family. Chabchoub G; Maalej A; Petit-Teixeira E; Glikmans E; Rebai A; Farid NR; Cornelis F; Ayadi H Clin Immunol; 2006 Aug; 120(2):235-6. PubMed ID: 16765647 [No Abstract] [Full Text] [Related]
35. [Thrombocytopenia and thyroid disease. Possible relation to anti-phospholipid antibodies]. Alarcón-Segovia D Rev Invest Clin; 1988; 40(1):113. PubMed ID: 3406556 [No Abstract] [Full Text] [Related]
36. Expression levels of the thyrotropin receptor gene in autoimmune thyroid disease: coregulation with parameters of thyroid function and inverse relation to major histocompatibility complex classes I and II. Schuppert F; Reiser M; Scheumann GF; Heldin NE; Pring-Akerblom P; Ede S; Haverkamp G; Dralle H; Von zur Mühlen A J Clin Endocrinol Metab; 1993 May; 76(5):1349-56. PubMed ID: 8496329 [TBL] [Abstract][Full Text] [Related]
37. Transgenic mice producing major histocompatibility complex class II molecules on thyroid cells do not develop apparent autoimmune thyroid diseases. Li YS; Kanamoto N; Hataya Y; Moriyama K; Hiratani H; Nakao K; Akamizu T Endocrinology; 2004 May; 145(5):2524-30. PubMed ID: 14764636 [TBL] [Abstract][Full Text] [Related]
38. Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor. Minich WB; Lenzner C; Morgenthaler NG Clin Exp Immunol; 2004 Apr; 136(1):129-36. PubMed ID: 15030524 [TBL] [Abstract][Full Text] [Related]